Vectormune HVT NDV from Ceva Animal Health contains a genetically engineered Marek’s disease virus of serotype 3 expressing a key protective antigen of Newcastle disease virus. This Marek’s disease vaccine is presented in a frozen cell-associated form. Vectormune HVT NDV is recommended for in-ovo administration in 18 to 19-day-old embryonated chicken eggs and for subcutaneous administration in day-old chicks.
Ceva Animal Health Vectormune HVT NDV vaccine
Fill out the form below to request more information about Ceva Animal Health Vectormune HVT NDV vaccine
More From Ceva Animal Health Inc.